Skip to main content
Year archive

Sinco Pharmaceuticals Holdings Limited — 2021 filings

All 142 regulatory filings released by Sinco Pharmaceuticals Holdings Limited (6833) in 2021, sourced directly from the official regulator.

142 Filings
2021 Period
2021 filings (142)
Filing Released Lang
EXTENSION OF COMPLETION DATE OF PLACING OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2021-12-30 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-12-29 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-12-29 English
VOLUNTARY ANNOUNCEMENT - INNOVATIVE MEDICINE "TCR1672" OBTAINED APPROVAL FOR CLINICAL TRIAL
Regulatory Filings
2021-12-21 English
VOLUNTARY ANNOUNCEMENT - EXCLUSIVE SALES AGREEMENT OF PENPULIMAB MONOCLONAL ANTIBODY
Regulatory Filings
2021-12-20 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-12-15 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2021-12-07 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-12-07 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 November 2021
Share Issue/Capital Change
2021-12-06 English
ANNOUNCEMENT PURSUANT TO RULE 13.18 OF THE LISTING RULES - FACILITY AGREEMENT WITH SPECIFIC PERFORMANCE COVENANTS
Capital/Financing Update
2021-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2021
Regulatory Filings
2021-12-01 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-11-11 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-11-08 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-11-05 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-11-03 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-11-02 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2021
Regulatory Filings
2021-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2021
Regulatory Filings
2021-11-01 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-10-29 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-10-28 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-10-27 English
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME
Transaction in Own Shares
2021-10-26 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-10-26 English
SUPPLEMENTAL ANNOUNCEMENT ON DISCLOSEABLE TRANSACTION IN RELATION TO THE TECHNOLOGICAL DEVELOPMENT PROJECT
Regulatory Filings
2021-10-21 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-10-21 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OF THE FIRST GENERIC "COLISTIMETHATE SODIUM FOR INJECTION" FOR MARKETING
Regulatory Filings
2021-10-15 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-10-12 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-10-08 English
VOLUNTARY ANNOUNCEMENT
Regulatory Filings
2021-10-08 English
VOLUNTARY ANNOUNCEMENT - IND APPLICATION OF INNOVATIVE MEDICINE "TCR1672" FILED WITH AND ACCEPTED BY FDA
Regulatory Filings
2021-10-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2021
Share Issue/Capital Change
2021-10-04 English
CESSATION TO FURTHER ANNOUNCE AND PUBLISH QUARTERLY FINANCIAL RESULTS
Regulatory Filings
2021-09-30 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2021
Regulatory Filings
2021-09-30 English
Next Day Disclosure Return
Share Issue/Capital Change
2021-09-28 English
COMPLETION OF SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2021-09-28 English
2021 INTERIM REPORT
Interim / Quarterly Report
2021-09-24 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS
Report Publication Announcement
2021-09-24 English
2021 INTERIM REPORT
Interim / Quarterly Report
2021-09-24 English
DISCLOSEABLE TRANSACTION IN RELATION TO THE TECHNOLOGICAL DEVELOPMENT PROJECT
Regulatory Filings
2021-09-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2021
Share Issue/Capital Change
2021-09-02 English
VOLUNTARY ANNOUNCEMENT - "SOFOSBUVIR TABLETS" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-09-01 English
VOLUNTARY ANNOUNCEMENT - "LENVATINIB MESILATE CAPSULE" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-09-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 August 2021
Regulatory Filings
2021-09-01 English
SECOND INTERIM DIVIDEND FOR 2021
Notice of Dividend Amount
2021-08-31 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE, 2021
Interim / Quarterly Report
2021-08-31 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2021
Interim / Quarterly Report
2021-08-30 English
POSITIVE PROFIT ALERT
Regulatory Filings
2021-08-18 English
DATE OF BOARD MEETING
Regulatory Filings
2021-08-18 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-08-13 English
POSITIVE PROFIT ALERT
Earnings Release
2021-08-11 English
VOLUNTARY ANNOUNCEMENT - "PENPULIMAB MONOCLONAL ANTIBODY INJECTION" OBTAINED MARKETING APPROVAL IN CHINA
Regulatory Filings
2021-08-05 English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF "PENPULIMAB" FOR THIRD-LINE TREATMENT OF METASTATIC NASOPHARYNGEAL CARCINOMA ACCEPTED BY NMPA
Regulatory Filings
2021-08-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2021
Regulatory Filings
2021-08-02 English
VOLUNTARY ANNOUNCEMENT - "AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM TABLET" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-08-02 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2021-08-02 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2021
Regulatory Filings
2021-08-02 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-07-30 English
VOLUNTARY ANNOUNCEMENT - "EDARAVONE INJECTION" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-07-29 English
SUPPLEMENTAL ANNOUNCEMENT SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2021-07-27 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares
2021-07-27 English
VOLUNTARY ANNOUNCEMENT - "VORTIOXETINE HYDROBROMIDE TABLETS" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-07-27 English
VOLUNTARY ANNOUNCEMENT - "LENVATINIB MESILATE CAPSULE" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-07-26 English
SUBSCRIPTION OF NEW SHARES UNDER GENERAL MANDATE
Capital/Financing Update
2021-07-23 English
VOLUNTARY ANNOUNCEMENT - "APREPITANT CAPSULES" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-07-16 English
VOLUNTARY ANNOUNCEMENT - "DEXMEDETOMIDINE HYDROCHLORIDE INJECTION" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-07-15 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2021
Capital/Financing Update
2021-07-06 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 June 2021
Share Issue/Capital Change
2021-07-02 English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF "PENPULIMAB" FOR FIRST-LINE TREATMENT OF SQUAMOUS NON-SMALL-CELL LUNG CANCER ACCEPTED BY NMPA
Regulatory Filings
2021-07-02 English
VOLUNTARY ANNOUNCEMENT - TENOFOVIR ALAFENAMIDE FUMARATE TABLETS OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-06-28 English
Environmental, Social and Governance Report 2020
Environmental & Social Information
2021-06-25 English
ADJUSTMENT TO CONVERSION PRICE OF EURO750,000,000 ZERO COUPON CONVERTIBLE BONDS DUE 2025
Capital/Financing Update
2021-06-16 English
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL RESULTS OF ANLOTINIB FOR THE TREATMENT OF SOLID TUMORS REPORTED AT THE 2021 ASCO ANNUAL MEETING
Regulatory Filings
2021-06-08 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 7 JUNE 2021
Declaration of Voting Results & Voting Rights Announcements
2021-06-07 English
VOLUNTARY ANNOUNCEMENT - "LINEZOLID AND GLUCOSE INJECTION" PASSES CONSISTENCY EVALUATION
Regulatory Filings
2021-06-02 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 1 JUNE 2021
Declaration of Voting Results & Voting Rights Announcements
2021-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2021
Share Issue/Capital Change
2021-06-01 English
VOLUNTARY ANNOUNCEMENT - "TOLVAPTAN TABLETS" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2021
Share Issue/Capital Change
2021-06-01 English
2020 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information
2021-05-27 English
VOLUNTARY ANNOUNCEMENT - "SUNITINIB MALATE CAPSULES" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-05-27 English
FIRST QUARTERLY RESULTS ANNOUNCEMENT FOR THE THREE MONTHS ENDED 31 MARCH, 2021
Interim / Quarterly Report
2021-05-24 English
VOLUNTARY ANNOUNCEMENT - PENPULIMAB SELECTED UNDER THE NEW POLICY OF REAL-TIME ONCOLOGY REVIEW OF FDA AND BLA SUBMITTED FOR THIRD-LINE TREATMENT OF NASOPHARYNGEAL CARCINOMA
Regulatory Filings
2021-05-24 English
VOLUNTARY ANNOUNCEMENT - "APREPITANT CAPSULES" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-05-20 English
VOLUNTARY ANNOUNCEMENT - "PALONOSETRON HYDROCHLORIDE INJECTION" PASSES CONSISTENCY EVALUATION
Regulatory Filings
2021-05-13 English
VOLUNTARY ANNOUNCEMENT - "DASATINIB TABLET" PASSES CONSISTENCY EVALUATION
Regulatory Filings
2021-05-12 English
VOLUNTARY ANNOUNCEMENT - APPOINTMENT OF CHIEF MEDICAL OFFICER
Board/Management Information
2021-05-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2021
Regulatory Filings
2021-05-03 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2021-05-03 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 April 2021
Share Issue/Capital Change
2021-05-03 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement
2021-04-29 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2021-04-29 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2021-04-29 English
VOLUNTARY ANNOUNCEMENT - "TIAN NENG" OBTAINS REGISTRATION CERTIFICATE OF FORMULA FOOD FOR SPECIAL MEDICAL PURPOSE
Regulatory Filings
2021-04-29 English
VOLUNTARY ANNOUNCEMENT - "SU QIAN" OBATAINS REGISTRATION CERTIFICATE OF FORMULA FOOD FOR SPECIAL MEDICAL PURPOSE
Regulatory Filings
2021-04-28 English
NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED HOLDERS
Report Publication Announcement
2021-04-22 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (OR ANY ADJOURNMENT THEREOF)
AGM Information
2021-04-22 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2021-04-22 English
GENERAL MANDATES TO ISSUE AND BUY BACK SHARES, RE-ELECTION OF DIRECTORS, AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2021-04-22 English
2020 ANNUAL REPORT
Annual Report
2021-04-22 English
Annual Report 2020
Annual Report
2021-04-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2021
Share Issue/Capital Change
2021-04-01 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020
Annual Report
2021-04-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2021
Share Issue/Capital Change
2021-04-01 English
CHANGE OF JOINT COMPANY SECRETARY CHANGE OF AUTHORISED REPRESENTATIVE AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
Board/Management Information
2021-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2020
Annual Report
2021-03-31 English
VOLUNTARY ANNOUNCEMENT - PENPULIMAB OBTAINED BREAKTHROUGH THERAPY DESIGNATION FROM FDA FOR THIRD-LINE TREATMENT OF METASTATIC NASOPHARYNGEAL CARCINOMA
Regulatory Filings
2021-03-30 English
VOLUNTARY ANNOUNCEMENT - ACQUISTION OF SOFTHALE
M&A Activity
2021-03-23 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER, 2020
Annual Report
2021-03-23 English
DATE OF BOARD MEETING
Regulatory Filings
2021-03-19 English
VOLUNTARY ANNOUNCEMENT - "DECITABINE FOR INJECTION" PASSES CONSISTENCY EVALUATION
Regulatory Filings
2021-03-12 English
VOLUNTARY ANNOUNCEMENT - "FOSAPREPITANT DIMEGLUMINE FOR INJECTION" OBTAINS FDA ANDA APPROVAL
Regulatory Filings
2021-03-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2021
Share Issue/Capital Change
2021-03-01 English
NOTIFICATION OF BOARD MEETING
Regulatory Filings
2021-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2021
Capital/Financing Update
2021-03-01 English
CHANGE OF ADDRESS OF SHARE REGISTRAR AND TRANSFER AGENT IN THE CAYMAN ISLANDS
Regulatory Filings
2021-02-26 English
POSITIVE PROFIT ALERT
Regulatory Filings
2021-02-25 English
VOLUNTARY ANNOUNCEMENT - "DOCETAXEL INJECTION" PASSES CONSISTENCY EVALUATION
Regulatory Filings
2021-02-25 English
VOLUNTARY ANNOUNCEMENT - INTERIM ANALYSIS OF THE PHASE III CLINICAL TRIAL OF PENPULIMAB IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE SQUAMOUS NONSMALL CELL LUNG CANCER HAS REACHED KEY ENDPOINTS
Regulatory Filings
2021-02-23 English
VONLUNTARY ANNOUNCEMENT - ENTERING INTO AN OVERSEAS LICENSING COOPERATION AGREEMENT WITH GRAVITON
Capital/Financing Update
2021-02-23 English
VOLUNTARY ANNOUNCEMENT "ALFACALCIDOL SOFT CAPSULE" PASSES CONSISTENCY EVALUATION
Regulatory Filings
2021-02-10 English
VOLUNTARY ANNOUNCEMENT - "PARECOXIB SODIUM FOR INJECTION" PASSES CONSISTENCY EVALUATION
Regulatory Filings
2021-02-09 English
VOLUNTARY ANNOUNCEMENT - "PARICALCITOL INJECTION" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-02-09 English
VOLUNTARY ANNOUNCEMENT- "ESOMEPRAZOLE MAGNESIUM ENTERIC-COATED CAPSULES" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-02-08 English
VOLUNTARY ANNOUNCEMENT - "EMPAGLIFLOZIN TABLETS" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-02-07 English
VOLUNTARY ANNOUNCEMENT - SINOVAC LS'S INACTIVATED NOVEL CORONAVIRUS VACCINE RECEIVES CONDITIONAL MARKETING APPROVAL
Regulatory Filings
2021-02-07 English
VOLUNTARY ANNOUNCEMENT - "ANLOTINIB HYDROCHLORIDE CAPSULES" OBTAINS APPROVAL FOR FOURTH INDICATION
Regulatory Filings
2021-02-04 English
INSIDE INFORMATION - PROPOSED ISSUE OF RMB SHARES AND LISTING ON THE SCI-TECH BOARD OF THE SHANGHAI STOCK EXCHANGE
Capital/Financing Update
2021-02-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2021
Share Issue/Capital Change
2021-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 January 2021
Share Issue/Capital Change
2021-02-01 English
VOLUNTARY ANNOUNCEMENT - "ZOLEDRONATE ACID INJECTION" OBTAINS APPROVAL FOR NEW INDICATION
Regulatory Filings
2021-01-25 English
CHANGE OF JOINT COMPANY SECRETARY CHANGE OF AUTHORISED REPRESENTATIVE AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES
Board/Management Information
2021-01-22 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "BORTEZOMIB FOR INJECTION"
Regulatory Filings
2021-01-22 English
VOLUNTARY ANNOUNCEMENT - LATEST STUDY OF PENPULIMAB IN COMBINATION WITH ANLOTINIB FOR 1L ADVANCED HCC PUBLISHED AT THE 2021 ASCO GI
Regulatory Filings
2021-01-20 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "PARECOXIB SODIUM FOR INJECTION"
Regulatory Filings
2021-01-11 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information
2021-01-08 English
RESIGNATION OF EXECUTIVE DIRECTOR AND CHANGE OF MEMBER OF BOARD COMMITTEE
Board/Management Information
2021-01-08 English
VOLUNTARY ANNOUNCEMENT - PASSING OF CONSISTENCY EVALUATION FOR "LINEZOLID AND GLUCOSE INJECTION"
Regulatory Filings
2021-01-07 English
VOLUNTARY ANNOUNCEMENT - "AFATINIB DIMALEATE TABLETS" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-01-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2020
Capital/Financing Update
2021-01-04 English
VOLUNTARY ANNOUNCEMENT - "ETORICOXIB TABLETS" OBTAINS DRUG REGISTRATION CERTIFICATE
Regulatory Filings
2021-01-04 English
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 December 2020
Share Issue/Capital Change
2021-01-04 English